Clinical Trials Logo

Ureteral Stent Occlusion clinical trials

View clinical trials related to Ureteral Stent Occlusion.

Filter by:
  • None
  • Page 1

NCT ID: NCT05455307 Recruiting - Hydronephrosis Clinical Trials

Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture

Allium
Start date: July 30, 2022
Phase: N/A
Study type: Interventional

To conduct a prospective, multi-center study to observe the long-term efficacy and safety of self expanding ureteral stent for treating participants with refractory ureteral stricture.

NCT ID: NCT04000178 Completed - Clinical trials for Ureteral Stent Occlusion

OPTIMAL STENTS DURING RENAL COLIC

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

From June 2018 to October 2018, patients from two distinct clinical centers were prospectively enrolled in the study and stratified (non-randomly) into either control group A, patients who received polyurethane stents (Rüsch, Teleflex), or experimental group B, patients who received silicone stents (Cook Medical). Each participant completed a survey one hour after stent insertion, in the middle of the stent dwelling period, and before stent removal or ureteroscopy noting body pain and overactive bladder via the visual analog scale pain (VASP) and overactive bladder (OAB) awareness tool, respectively. Additionally, the successfulness of stent placement, hematuria, number of unplanned visits, and stent encrustation rates were assessed within each group.

NCT ID: NCT01310582 Completed - Vaginal Diseases Clinical Trials

Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females

Start date: May 2011
Phase: Phase 4
Study type: Interventional

Numerous studies demonstrate that patients have improved immediate recovery characteristics following desflurane anesthesia compared to other volatile agents, including sevoflurane. There is limited evidence in the literature to suggest that patients undergoing sevoflurane, compared to desflurane anesthesia, may suffer from limitation in function and cognitive ability for an undetermined, but prolonged period of time following surgery. These differences are not explained pharmacokinetically and may be a result of a direct neurotoxic effect of sevoflurane. An unresolved question is the time required for the ability to return to complex tasks, such as driving, following anesthesia. Commonly, patients are advised not to drive or make important decisions for 24 hours following anesthesia, but this is not well-studied and proscribed on an empiric, rather than scientific, basis with very limited data available.This study will better define recovery characteristics and characterize the severity and duration of cognitive impairment following sevoflurane or desflurane anesthesia after brief outpatient urologic surgery in elderly females using tests of cognitive ability coupled with performance on a driving simulator and cognitive task tests to objectively measure not only testing performance, but also cognitive effort in performing these tests.